The Taiwan Ministry of Health and Welfare has delivered registration for Guerbet's contrast media kit Vectorio.
Vectorio is a mixing and injection system for administering Guerbet's Lipiodol Ultra Fluid plus an anticancer drug during transarterial chemoembolization procedures. It is designed for adults with intermediate-stage hepatocellular carcinoma.
The system received the European CE Mark in August 2017 and officially launched in September 2017. It is currently registered in 25 countries.
